Effect of the CYP2C19 Polymorphism in Helicobacter Pylori Eradication

Clinical trial NCT03650543 · COMPLETED

Trial details

NCT number: NCT03650543
Sponsor: Javeriana University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

CYP2C19 Polymorphism H.Pylori Infection Therapy

Start date: 2012-09-10
Primary completion: 2015-08-08
Enrollment: 133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.